{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "When Audrey Eisen flicked her computer on last Monday night and read the news that the painkiller Aleve had been linked to heart attacks, she winced in disbelief. Ms. Eisen, 64, a retired professor who lives in New York, had just returned from her drugstore with a package of Aleve. Her pharmacist allowed her to return it the next morning, no questions asked.", "headline": {"main": "Vioxx. Celebrex. Now Aleve. What's a Patient to Think?"}, "abstract": null, "print_page": "5", "word_count": 1626, "_id": "4fd24a448eb7c8105d7e7e74", "snippet": "Many Americans who have relied on pain pills say their faith in the system intended to protect them has been eroded.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/12/28/health/policy/28pain.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "RECALLS AND BANS OF PRODUCTS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Anahad", "rank": 1, "lastname": "O'CONNOR"}], "original": "By ANAHAD O'CONNOR"}, "document_type": "article", "pub_date": "2004-12-28T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "As a primary human drive, not even the pursuit of prolonged pleasure can compete with the avoidance of pain. That is why the sudden emergence of the painkiller issue strikes home to so many who are afflicted with pain ranging from splitting headache to crippling arthritis. In recent weeks, people seeking relief have been afflicted by the overreaction to reports that several new pain alleviators, taken in large doses by especially vulnerable patients, may increase the risk of heart problems. These new, expensive medicines were developed to reduce pain without the risk of side effects like ulcers that were associated with established painkillers. Within days, other studies surfaced to generate worry about the side effects of sustained high doses of those familiar medicines -- naproxen, ibuprofen, even century-old aspirin.", "headline": {"main": "A World Of Hurt"}, "abstract": "William Safire Op-Ed column scoffs at what he calls panicked ideas regarding pain-killing drugs; offers his suggestions about what should be done to give doctors and patients enough information to intelligently balance risk of taking suspect pain-relieving drugs against risk or pain of doing without (M)", "print_page": "17", "word_count": 711, "_id": "4fd25a6f8eb7c8105d807273", "snippet": "As a primary human drive, not even the pursuit of prolonged pleasure can compete with the avoidance of pain. That is why the sudden emergence of the painkiller issue strikes home to so many who are afflicted with pain ranging from splitting headache...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=990DE6DA1F30F934A15751C1A9629C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PAIN"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "William", "rank": 1, "lastname": "SAFIRE"}], "original": "By WILLIAM SAFIRE"}, "document_type": "article", "pub_date": "2004-12-27T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The federal government is now telling patients whether their local hospitals are doing what they should. For now, the effort involves three common and deadly afflictions of the elderly -- heart attacks, heart failure and pneumonia -- and asks about lifesaving treatments that everyone agrees should be given but that hospitals and doctors often forget to give.", "headline": {"main": "Program Coaxes Hospitals to See Treatments Under Their Noses"}, "abstract": "Federal government is telling patients whether their local hospitals are doing what they should; effort involves three common and deadly afflictions of elderly--heart attacks, heart failure and pneumonia--and asks about lifesaving treatments that everyone agrees should be given but that hospitals and doctors often forget to give; it is bold effort by federal government, along with organizations of hospitals, doctors, nurses and health researchers, to push providers to use proven remedies for common ailments; hospital ratings are done by Medicare and posted on Internet (M)", "print_page": "1", "word_count": 1974, "_id": "4fd2809a8eb7c8105d84c0d7", "snippet": "The federal government is now pushing health providers to use proven remedies for common ailments.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/12/25/health/25medicine.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "HEART"}, {"name": "subject", "value": "NURSING AND NURSES"}, {"name": "subject", "value": "RATINGS AND RATING SYSTEMS"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "HOSPITALS"}, {"name": "subject", "value": "PNEUMONIA"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gina", "rank": 1, "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2004-12-25T00:00:00Z", "section_name": "Front Page; Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Food and Drug Administration recommended Thursday that doctors limit prescriptions for the popular pain pills Celebrex and Bextra because recent studies have suggested that they may increase the risk of heart attack and stroke. The agency's advisory did not ban prescriptions of the drugs for any group of patients, instead simply telling doctors to use their best judgment in light of those studies. Indeed, it said patients who were at high risk of gastrointestinal bleeding or had done poorly on other pain pills ''may be appropriate candidates'' for Celebrex and Bextra.", "headline": {"main": "F.D.A. Urges Doctors to Limit Their Prescriptions for a Pair of Popular Painkillers"}, "abstract": "FDA recommends doctors limit prescriptions for arthritis pain pills Celebrex and Bextra because recent studies suggest increased risk of heart attack and stroke; says patients at high risk for gastrointestinal bleeding or those who have done poorly on other medication may still be appropriate candidates for two drugs; also warns consumers to pay close attention to directions for over-the-counter drugs; British authorities have urged immediate switch; Dr Sidney Wolfe of health watchdog group charges FDA sides with Pfizer in refusing to ban two drugs (M)", "print_page": "17", "word_count": 874, "_id": "4fd257118eb7c8105d800cb8", "snippet": "Recent studies have suggested that Celebrex and Bextra may increase the risk of heart attack and stroke.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/12/24/politics/24fda.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "WOLFE, SIDNEY"}, {"name": "glocations", "value": "GREAT BRITAIN"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "PFIZER INC"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "CELEBREX (DRUG)"}, {"name": "subject", "value": "BEXTRA (DRUG)"}, {"name": "subject", "value": "STROKE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PAIN"}, {"name": "subject", "value": "ARTHRITIS AND RHEUMATISM"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "RECALLS AND BANS OF PRODUCTS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gardiner", "rank": 1, "lastname": "HARRIS"}, {"organization": "", "role": "reported", "firstname": "Alex", "rank": 2, "lastname": "BERENSON"}], "original": "By GARDINER HARRIS and ALEX BERENSON; Gardiner Harris reported from Washington for this article, and Alex Berenson from New York"}, "document_type": "article", "pub_date": "2004-12-24T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "AstraZeneca's recent full-page newspaper advertisements defending the safety of its cholesterol-lowering pill, Crestor, are ''false and misleading,'' in part because serious concerns remain about the safety of the drug, federal drug regulators said Wednesday. The advertisements stated that ''the F.D.A. has confidence in the safety and efficacy of Crestor'' and that the agency ''as recently as last Friday publicly confirmed that Crestor is safe and effective.'' Neither is true, said a letter from the Food and Drug Administration to AstraZeneca.", "headline": {"main": "Federal Drug Agency Calls Ads for the Cholesterol Pill Crestor 'False and Misleading'"}, "abstract": "Food and Drug Administration calls AstraZeneca's ads defending safety of its cholesterol-lowering pill Crestor 'false and misleading;' ads say FDA 'has confidence' in drug's safety and that agency 'publicly confirmed that Crestor is safe and effective,' but FDA refutes both assertions and in days leading to ad, top agency officials publicly expressed concern about drug's safety; Public Citizen says ads misrepresent FDA's position (M)", "print_page": "16", "word_count": 899, "_id": "4fd2414e8eb7c8105d7d9a10", "snippet": "AstraZeneca's advertisements defending Crestor were criticized in part because concerns remain about the drug's safety.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/12/23/politics/23fda.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "ASTRAZENECA PLC"}, {"name": "organizations", "value": "PUBLIC CITIZEN"}, {"name": "organizations", "value": "ASTRAZENECA"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "ADVERTISING"}, {"name": "subject", "value": "MISLEADING AND DECEPTIVE ADVERTISING"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CRESTOR (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gardiner", "rank": 1, "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2004-12-23T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 5, "offset": 0, "time": 34}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}